Did we see it Coming? An Evaluation of the Swedish Early Awareness and Alert System
Author:
Funder
Sveriges Kommuner och Landsting
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics and Econometrics,General Medicine
Link
http://link.springer.com/article/10.1007/s40258-018-0434-2/fulltext.html
Reference30 articles.
1. Kelly RJ, Smith TJ. Delivering maximum clinical benefit at an affordable price: engaging stakeholders in cancer care. Lancet Oncol. 2014;15(3):e112–8.
2. Howard DH, Bach PB, Berndt ER, Conti RM. Pricing in the market for anticancer drugs. J Econ Perspect. 2015;29(1):139–62.
3. Goulart BH. Value: the next frontier in cancer care. Oncologist. 2016;21(6):651–3.
4. Iyengar S, Tay-Teo K, Vogler S, Beyer P, Wiktor S, de Joncheere K, et al. Prices, costs, and affordability of new medicines for hepatitis C in 30 countries: an economic analysis. PLoS Med. 2016;13(5):e1002032.
5. Morel T, Arickx F, Befrits G, Siviero P, van der Meijden C, Xoxi E, et al. Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries. Orphanet J Rare Dis. 2013;8:198.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Analysis of actual results of drug supply implementation within framework of High-Cost Nosologies Program;Pharmacy & Pharmacology;2024-05-07
2. Evidence-based public policy making for medicines across countries: findings and implications for the future;Journal of Comparative Effectiveness Research;2021-08
3. Budget impact analysis of medicines: estimated values versus real-world evidence and the implications;Expert Review of Pharmacoeconomics & Outcomes Research;2021-05-27
4. Horizon Scanning for pharmaceuticals and effective health care programming: 2 years’ experience at the Italian Medicines Agency;Drug Discovery Today;2021-02
5. Health authority activities to enhance the quality and efficiency of medicine use and their impact;Advances in Human Biology;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3